Etoposide/irinotecanLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-24995-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：259 / 259

相关论文

共 50 条

[31] Carboplatin/etoposide/imatinibLack of efficacy: case report
Reactions Weekly, 2022, 1912 (1) : 135 - 135
[32] Carboplatin/etoposide/ifosfamideLack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 128 - 128
[33] Carboplatin/Etoposide/IfosfamideLack of efficacy: case report
Reactions Weekly, 2024, 2024 (1) : 121 - 121
[34] Carboplatin/etoposide/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1940 (1) : 126 - 126
[35] Carboplatin/etoposide/ifosfamideLack of efficacy: case report
Reactions Weekly, 2021, 1856 (1) : 126 - 126
[36] Carboplatin/etoposide/vincristineLack of efficacy: case report
Reactions Weekly, 2024, 2035 (1) : 134 - 134
[37] Carboplatin/etoposide/ifosfamideLack of efficacy: case report
Reactions Weekly, 2022, 1927 (1) : 154 - 154
[38] Carboplatin/Etoposide/VismodegibLack of efficacy: case report
Reactions Weekly, 2024, 2032 (1) : 111 - 111
[39] Carboplatin/etoposide/paclitaxelLack of efficacy: case report
Reactions Weekly, 2022, 1917 (1) : 155 - 155
[40] Carboplatin/Etoposide/VincristineLack of efficacy: case report
Reactions Weekly, 2025, 2047 (1) : 104 - 104

← 1 2 3 4 5 →